Preprints.org · Aug 20, 2026

Chronic Migraine and Alzheimer’s Dementia: A Candidate Mechanistic Route, and the Evidence That Would Test It

By Sulter GA

Objective: To establish whether the published epidemiological record can support or refute the proposition that chronic migraine is a modifiable midlife contributor to Alzheimer’s dementia, and to specify the studies that would settle the question. Background: Migraine is repeatedly reported as a dementia risk factor and has been proposed for addition to the list of modifiable risks. A route from recurrent cortical spreading depolarization through perivascular clearance failure to amyloid aggregation, and onward through pannexin-1–HMGB1–toll-like-receptor transduction to sustained neuroinflammation, is biologically coherent. Whether the epidemiology actually tests that route has not been examined. Methods: Narrative review. PubMed, Google Scholar and CrossRef were searched from January 2020 to August 2026, with hand-searching for seminal earlier work. Following an internal audit, every quantitative claim was re-derived from the source record rather than from an earlier draft, and claims that could not be so derived were removed. Results: The association declines monotonically as control over ascertainment improves. For primary headache the odds ratio is 1.49 (95% CI 1.20–1.85) in case-control studies, 1.35 (1.25–1.45) in retrospective cohorts and 0.82 (0.74–0.92) in prospective cohorts, the last significantly below the null. Heterogeneity falls from I2 85.9% undivided to 9.2%, 61.9% and 26.9% within design strata, and small-study effects appear only in the middle stratum. Attack frequency has never been related to dementia incidence in any cohort; the one study that measured frequency directly reported no direct association with its brain-age gap, alongside a positive indirect path through segmented brain volume in a design with a truncated exposure range. Chronicity has never been stratified against episodic migraine. No adequate aura-stratified evidence exists, so aura supports neither the model nor its negation. Across pain phenotypes migraine ranks fifth of six, below trigeminal neuralgia and fibromyalgia, neither of which involves depolarization, and the source authors attribute their own top-ranked estimate to depression. Risk attenuates with time since the first diagnostic code and remains elevated beyond ten years. Conclusion: These findings share one cause: exposure is recorded as a diagnosis and not measured as disease activity, so the coded date marks clinical contact and not disease onset, and the interval between the two differs systematically across phenotypes and designs. The proposition is untested, not refuted. A falsifiable prediction follows, together with a cross-sectional plasma-biomarker comparison that would substantially weaken the hypothesis if null and open the frequency question if positive, at a fraction of the cost of an imaging program. Plain Language Summary: Migraine has been named as a possible cause of dementia in later life, but no long-term study has asked whether people with more attacks go on to develop it. We reviewed the evidence and found the link weakens, then reverses, in the studies that follow patients most closely. These studies record a diagnosis and not the illness itself, so the question stays open; one blood test study would go a long way toward answering it.

doi.org/10.20944/preprints202605.0132.v2Open accessPopulations

AgingResearch.News